[1]
Al-Muhsen S, Clarke AE, Kagan RS. Peanut allergy: an overview. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne. 2003 May 13:168(10):1279-85
[PubMed PMID: 12743075]
Level 3 (low-level) evidence
[2]
Sicherer SH, Sampson HA. Peanut and tree nut allergy. Current opinion in pediatrics. 2000 Dec:12(6):567-73
[PubMed PMID: 11106277]
Level 3 (low-level) evidence
[3]
Finkelman FD. Peanut allergy and anaphylaxis. Current opinion in immunology. 2010 Dec:22(6):783-8. doi: 10.1016/j.coi.2010.10.005. Epub 2010 Nov 2
[PubMed PMID: 21051210]
Level 3 (low-level) evidence
[4]
Stiefel G, Anagnostou K, Boyle RJ, Brathwaite N, Ewan P, Fox AT, Huber P, Luyt D, Till SJ, Venter C, Clark AT. BSACI guideline for the diagnosis and management of peanut and tree nut allergy. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology. 2017 Jun:47(6):719-739. doi: 10.1111/cea.12957. Epub
[PubMed PMID: 28836701]
[5]
Du Toit G, Roberts G, Sayre PH, Bahnson HT, Radulovic S, Santos AF, Brough HA, Phippard D, Basting M, Feeney M, Turcanu V, Sever ML, Gomez Lorenzo M, Plaut M, Lack G, LEAP Study Team. Randomized trial of peanut consumption in infants at risk for peanut allergy. The New England journal of medicine. 2015 Feb 26:372(9):803-13. doi: 10.1056/NEJMoa1414850. Epub 2015 Feb 23
[PubMed PMID: 25705822]
Level 1 (high-level) evidence
[6]
Rabjohn P, Helm EM, Stanley JS, West CM, Sampson HA, Burks AW, Bannon GA. Molecular cloning and epitope analysis of the peanut allergen Ara h 3. The Journal of clinical investigation. 1999 Feb:103(4):535-42
[PubMed PMID: 10021462]
[7]
Stanley JS, King N, Burks AW, Huang SK, Sampson H, Cockrell G, Helm RM, West CM, Bannon GA. Identification and mutational analysis of the immunodominant IgE binding epitopes of the major peanut allergen Ara h 2. Archives of biochemistry and biophysics. 1997 Jun 15:342(2):244-53
[PubMed PMID: 9186485]
[8]
Sicherer SH, Forman JA, Noone SA. Use assessment of self-administered epinephrine among food-allergic children and pediatricians. Pediatrics. 2000 Feb:105(2):359-62
[PubMed PMID: 10654956]
[9]
Boyce JA, Assa'ad A, Burks AW, Jones SM, Sampson HA, Wood RA, Plaut M, Cooper SF, Fenton MJ, Arshad SH, Bahna SL, Beck LA, Byrd-Bredbenner C, Camargo CA Jr, Eichenfield L, Furuta GT, Hanifin JM, Jones C, Kraft M, Levy BD, Lieberman P, Luccioli S, McCall KM, Schneider LC, Simon RA, Simons FE, Teach SJ, Yawn BP, Schwaninger JM, NIAID-Sponsored Expert Panel. Guidelines for the Diagnosis and Management of Food Allergy in the United States: Summary of the NIAID-Sponsored Expert Panel Report. The Journal of allergy and clinical immunology. 2010 Dec:126(6):1105-18. doi: 10.1016/j.jaci.2010.10.008. Epub
[PubMed PMID: 21134568]
[10]
Bublin M, Breiteneder H. Developing therapies for peanut allergy. International archives of allergy and immunology. 2014:165(3):179-94. doi: 10.1159/000369340. Epub 2014 Dec 20
[PubMed PMID: 25531161]
[11]
Sicherer SH, Noone SA, Muñoz-Furlong A. The impact of childhood food allergy on quality of life. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology. 2001 Dec:87(6):461-4
[PubMed PMID: 11770692]
Level 2 (mid-level) evidence
[12]
Primeau MN, Kagan R, Joseph L, Lim H, Dufresne C, Duffy C, Prhcal D, Clarke A. The psychological burden of peanut allergy as perceived by adults with peanut allergy and the parents of peanut-allergic children. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology. 2000 Aug:30(8):1135-43
[PubMed PMID: 10931121]